score:12
Chances:
- Boston Scientific’s (BSX) FARAPULSE System Study Data Positive
- Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion
- Boston Scientific Leads the S&P 500
- Boston Scientific Reports Positive Results from Atrial Fibrillation Device
- ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Risks:
- Boston Scientific Stock Gets 81 RS Rating After Profit Pops 56% In Year
- EVP & Grp Pres, MedSurg & APAC Arthur Butcher Sells 6,600 Shares of Boston Scientific …
- Ozempic Is All the Rage. And That Might Explain a Mysterious Stock Selloff.
- Boston Scientific plans new campus in Maple Grove
- Will Boston Scientific (BSX) Beat Q2 Earnings Estimates?
Score:12
investment score = chances characters count - risks characters count
References:
- 2023-09-01 Boston Scientific’s (BSX) FARAPULSE System Study Data Positive
- 2023-08-31 The Petri Dish: Boston Scientific device succeeds in trial, Sanofi vet joins Flagship
- 2023-08-30 If You Invested $1000 in Boston Scientific a Decade Ago, This is How Much It’d Be Worth Now
- 2023-08-29 PBH vs. BSX: Which Stock Should Value Investors Buy Now?
- 2023-08-29 Company News for Aug 29, 2023
- 2023-08-29 S&P 500 Gains and Losses Today: Index Adds to Last Week’s Advance After Powell’s Comments
- 2023-08-29 Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion
- 2023-08-29 Boston Scientific Leads the S&P 500
- 2023-08-28 Boston Scientific Reports Positive Results from Atrial Fibrillation Device
- 2023-08-28 Unveiling Boston Scientific (BSX)’s Value: Is It Really Priced Right? A Comprehensive Guide